| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |